Collins James J. 4
4 · Senti Biosciences, Inc. · Filed Jul 15, 2022
Insider Transaction Report
Form 4
Collins James J.
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-07-13+125,000→ 125,000 totalExercise: $1.75Exp: 2032-07-12→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest in 36 substantially equal monthly installments over three years from July 13, 2022, subject to the reporting person's continued service through the applicable vesting date. The vested shares subject to such option shall be exercisable upon the effectiveness of the Issuer's registration statement on Form S-8, registering the shares of the Issuer's 2022 Equity Incentive Plan with the U.S. Securities and Exchange Commission.